Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged >= 50 Years: A Single-Center Experience Over Two Decades
- AR, MUHLİS CEM
- ÖNGÖREN, ŞENİZ
- BAŞLAR, ZAFER
- EŞKAZAN, AHMET EMRE
- Cokgezer, Simay
- ELVERDİ, TUĞRUL
- SALİHOĞLU, AYŞE
Publication date
July 2022
DOI Publisher
Dove Medical Press Ltd. Journal
Cancer Management and ResearchAbstract
Introduction: The aim of this study was to evaluate treatment responses, toxicity, and survival among cHL patients aged >= 50 years
Add to ORKG